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INTRODUCTION
Candidiasis is one of the most frequent fungal disease in humans, comprising a broad spectrum of opportunistic infections ranging from mucocutaneous to invasive mycoses (Brown et al. 2012) . Factors responsible for the rise of nosocomial fungal infections include the increasing population under medical treatments as a result of the advances in health-care assistance, such as the use of intensive chemotherapy and immunosuppressive drugs (Perlroth, Choi and Spellberg 2007) . Candida haemulonii complex (C. haemulonii, C. duobushaemulonii and C. haemulonii var. vulnera) and closely related species like C. auris are some of the rare non-albicans Candida (NAC) species that until recently were mistakenly identified but have emerged as notorious healthcare-associated yeasts causing invasive infections with high rates of clinical treatment failures (Ben-Ami et al. 2017; Sarma and Upadhyay 2017) . In this context, antifungal susceptibility is an important concern in managing C. haemulonii complex infections because these species have demonstrated resistance to the first-line antifungal agents (e.g. fluconazole and amphotericin B). Additionally, a number of potential virulence attributes have been recognized in these fungal species, including the capacity to form biofilms in medical devices (Oh et al. 2011; Gandra et al. 2017; and to produce tissue-damaging enzymes (e.g. proteases, lipases and hemolysins) (Ramos, Branquinha and Santos 2016) .
Over the last few years, the scientific community has been particularly interested in developing non-mammalian host models to study microbial virulence in order to deviate from the huge ethical impact of the classical animal tests and to increase the possibility of large-scale screening studies (TrevijanoContador and Zaragoza 2014) . In this context, Galleria mellonella is an invertebrate animal that became a useful host model to study the virulence of different microorganisms and to evaluate drug efficacy (Ramarao, Nielsen-Leroux and Lereclus 2012; Cook and McArthur 2013; Jacobsen 2014) . The purpose of the present work was to evaluate the species-related variations regarding pathogenicity of the three species belonging to the C. haemulonii complex and other three NAC species (C. tropicalis, C. krusei and C. lusitaniae) in the G. mellonella model and to correlate in vitro and in vivo antifungal profiles. This study was performed by comparison of (i) larvae survival during fungal infection progression, (ii) fungal burden counts during the infectious process, (iii) hemocyte density during the infectious process, (iv) in vivo phagocytic potential, (v) histological changes in G. mellonella tissues, and (vi) ability of fungal cells to produce potential virulence attributes before and after the larvae infection.
MATERIAL AND METHODS

Fungal strains and growth conditions
Nine clinical isolates of C. haemulonii complex were used in this study: C. haemulonii (LIPCh2, LIPCh3, LIPCh4 and LIPCh7), C. duobushaemulonii (LIPCh1, LIPCh6 and LIPCh8) and C. haemulonii var. vulnera (LIPCh5 and LIPCh9) (Ramos et al. 2015) . Additionally, three standard strains were used for comparative purposes: C. tropicalis (ATCC 750), C. krusei (ATCC 6258) and C. lusitaniae (ATCC 200950) . Fungal cells were grown in Sabouraud-dextrose liquid medium (SAB) at 37
• C for 24 h with shaking (120 rpm).
Growth curves
Growth curves in SAB were determined for all the fungal species. Suspensions of each NAC species at 10 6 fungi/mL were prepared in SAB and inoculated in a 96-well plate (200 μL/well) at 37
• C. Optical density at 540 nm was measured up to 96 h in a spectrophotometer (Spectramax M2e Molecular Devices, San Jose, California, USA).
Biofilm formation
To evaluate biofilm formation, fungal suspensions in SAB (200 μL/well containing 10 6 fungi) were transferred to sterile 96-well plates (Costar 3599; Corning Inc., New York, USA) and then incubated at 37
• C. After 48 h, the supernatants were carefully removed and the wells were washed with saline to remove non-adherent cells. The biomass quantification was assessed in a microplate reader in a spectrophotometer (Spectramax M2e Molecular Devices, San Jose, California, USA) at 590 nm after crystal violet staining of methanol-fixed biofilms. The metabolic activity of the biofilm was determined using a colorimetric assay, which measures the metabolic reduction of 2,3-bis (2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino) carbonyl]-2H-tetrazolium hydroxide (XTT; Sigma-Aldrich, St. Louis, Missouri, USA) to a water-soluble brown formazan product, at 492 nm. The extracellular matrix was quantified at 530 nm in the same spectrophotometer after safranin impregnation in nonfixed biofilms (Mello et al. 2016; .
Production of extracellular hydrolytic enzymes
The determination of aspartic protease, caseinase, phospholipase, esterase and phytase activities was assayed using classical plate methods (Abi-chacra et al. 2013; Ramos, Branquinha and Santos 2016) . The colony diameter (a) and the diameter of colony plus precipitation/degradation zone (b) were measured, and the enzymatic activities were expressed as Pz value (a/b) (Price, Wilkinson and Gentry 1982) . The Pz value was scored into three categories: high Pz between 0.999 and 0.700 (weak producers), moderate Pz between 0.699 and 0.400 (good producers) and low Pz between 0.399 and 0.100 (excellent producers). According to this definition, low Pz values mean high enzyme production and, inversely, high Pz values indicate low enzymatic production (Price, Wilkinson and Gentry 1982) .
Antifungal susceptibility assay
Antifungal susceptibility testing was performed according to the standardized broth microdilution technique described by 
Galleria mellonella assays
Larvae rearing and manipulation Galleria mellonella larvae were maintained and fed as previously described until reaching 220-280 mg in weight (Silva et al. 2017) . During survival assays, larvae (10 per each assayed group) were incubated at 37
• C. Larvae were assessed daily, up to 5 days posttreatment, to check their survival, being scored as dead when they displayed no movement in response to touch. For survival assays, fungi were grown overnight in liquid SAB, washed with sterile phosphate-buffered saline (PBS; 150 mM NaCl, 20 mM phosphate buffer, pH 7.2) and suspended in the same buffer. Cell density was estimated by counting cells in a Neubauer chamber, which was confirmed by colony-forming unit (CFU) counts in SAB agar. The curves were performed through injection of different fungal inocula (1 × 10 6 , 3 × 10 6 , 6 × 10 6 and 9 × 10 6 fungi/larva) in order to determine the appropriate concentration to be injected in the subsequent experiments. Each inoculum was injected through the last right proleg of the larva using a 10-μL syringe (Hamilton, Hamilton Company Reno, NV, USA).
Larvae treatment with antifungal drugs
The inoculum concentration that caused an average of 80% of larvae killing after 5 days of infection (3 × 10 6 CFU/larva for C.
tropicalis and C. lusitaniae and 6 × 10 6 CFU/larva for C. krusei and C. haemulonni species complex) was selected for antifungal experiments. After 30 min of fungal infection, larvae received 10 μL of antifungals (FLC, AMB and CAS) in the last left proleg and were incubated at 37
• C. The following groups were included:
DMSO (larvae inoculated with the vehicle solution containing 2% DMSO in PBS), toxicity drug control (non-infected larvae inoculated with the highest concentration of each antifungal), negative control (larvae inoculated with NAC species and treated with PBS) and treatment systems (larvae inoculated with NAC species and treated with the antifungals). The administered antifungal doses corresponded to those recommended for humans to treat invasive candidiasis or candidemia (Pappas et al. 2015) . To simplify figures presentation, the DMSO control group and toxicity drug control are not presented.
Hemocytes' density determination in the hemolymph
Groups of 10 larvae were inoculated with 6 × 10 6 fungal cells and then incubated at 37 • C for 2 and 8 h. After each time interval, 30 μL of hemolymph were collected in insect physiological saline buffer (IPS; 150 mM sodium chloride, 5 mM potassium chloride, 10 mM Tris-HCl, pH 6.9, 10 mM EDTA and 30 mM sodium citrate) (Scorzoni et al. 2013) . After a 1:10 dilution in IPS, hemocytes density was counted using a hemocytometer. Results were expressed as hemocytes/mL.
In vivo phagocytosis assay
A suspension of 6 × 10 8 cells/mL was initially stained with 10 mg/L of Calcofluor white (Sigma-Aldrich, St. Louis, Missouri, USA) for 30 min at 37
• C, and 10 μL were injected in groups of five larvae. Hemolymph was recollected in 1:10 IPS buffer after 2 h and then centrifuged at 78 g for 4 min. The pellet was fixed with 2% paraformaldehyde for 30 min, cells were placed on slides, covered and immediately analyzed in an Axioskop 40 optical microscope (Zeiss, Jena, Germany). A total of 100 insect cells per treatment were counted and the percentage of hemocytes containing fungal cells was calculated (Scorzoni et al. 2013) .
Fungal burden determination
According to the protocols modified by Mesa-Arango et al. (2013) , groups of five larvae were infected with 3 × 10 6 cells of C.
tropicalis and C. lusitaniae and 6 × 10 6 cells of C. krusei and C.
haemulonni species complex. FLC, AMB or CAS were administered 30 min after fungal infection in a single dose. Immediately after the treatment (time 0 h) and after 48 h, 30 μL of hemolymph were collected and diluted 1:10 in IPS buffer, then serial dilutions were made onto SAB plus 40 mg/L of streptomycin (SigmaAldrich, St. Louis, Missouri, USA) agar plates. The plates were incubated during 48 h at 37
• C, and CFUs were enumerated.
Quantification of larvae melanization
Larvae were infected with PBS or 6 × 10 6 fungi, and the hemolymph of each larva was collected after 2 and 24 h and then diluted 1:10 with IPS buffer. The samples were placed in 96-well microdilution plates. To quantify melanin levels, OD 405 was measured in a spectrophotometer (Spectramax M2e Molecular Devices, San Jose, California, USA) (Scorzoni et al. 2013) . In parallel, photographs were taken in order to visualize the melanization process in the larvae.
Histological study of larvae tissues
Three larvae per group were fixed after 24 h of infection in 10% buffered formalin and dehydrated with increasing concentrations of ethanol. The samples were then treated with xylene and embedded in paraffin. Tissue sections of 3 μm were stained with periodic acid Schiff and sections examined with an Axio Imager M.2 optical microscope (Zeiss, Jena, Germany).
Biofilm formation and production of hydrolytic enzymes in postlarvae passage Larvae were infected with PBS or 6 × 10 6 fungi. The hemolymph of five larvae per group was collected after 48 h and then diluted 1:10 with IPS buffer. The samples were placed onto SAB plus 40 mg/L of streptomycin (Sigma-Aldrich, St. Louis, Missouri, USA) agar plates. Fungi were allowed to grow for 48 h, subsequently resuspended in SAB broth and both biofilm formation and hydrolytic enzymes' production were measured as described above.
Statistics
Data were analyzed by the Student t-test in relation to the untreated samples and statistical differences were expressed as * P ≤ 0.05 and * * P ≤ 0.01. Survival analyses were determined using the log-rank test and the Kaplan-Meier survival curves. Significance level in G. mellonella fungal burden assay was analyzed by two-way ANOVA with Bonferroni post test.
RESULTS
Virulence of NAC species in G. mellonella is dependent on the fungal species and inoculum size
First, the larvae were infected with different concentrations of fungal cells and the results showed a typical dose-dependent effect on the larvae killing (Fig. 1) . Candida tropicalis and C. lusitaniae exhibited greater virulence than C. krusei and members of the C. haemulonii species complex (Table 1) . Regarding the virulence profile, no differences among the three species forming the C. haemulonii complex were seen ( Fig. 1 and Table S2 , Supporting Information). Doses of 3 × 10 6 CFU/larva for C. tropicalis and C. The results compare the pathogenicity of the studied Candida species with one another, when they were inoculated in G. mellonella at the same inoculum concentration (3 × 10 6 fungi/larva). P >0.001 as determined using the log-rank (Mantel-Cox) test is given for all the Candida species combinations where a given species (horizontal axis) was more pathogenic than another (vertical axis); ns, not statistically significant (P < 0.001).
lusitaniae and 6 × 10 6 CFU/larva for C. krusei and C. haemulonii species complex were selected for antifungal drug treatments, since these doses showed a gradual reduction in the survival rate throughout the whole experimental period (average of 80% of larvae killing after 5 days of infection).
Modulation of immune response of G. mellonella after infection with NAC species
Fungal inoculation caused early melanization of the larvae after some minutes of injection and an augmented pigmentation after 24 h ( Fig. 2A) . When larvae were infected with 6 × 10 6 fungi cells, there was a significant accumulation of melanin in the hemolymph after 2 h (at least two times higher when compared to non-infected larvae), and this melanization increased progressively over time (five times at 24 h post-infection, Fig. 2B ). Subsequently, we examined whether different NAC species had any effect in altering hemocytes' density. As shown in Fig. 2C , all the Candida species decreased hemocyte density in a similar manner when compared to the control group, as observed 2 h and 8 h post-infection. Since phagocytosis is important for fungal infection clearance in G. mellonella, we also studied the functional viability of larval hemocytes. All the fungal species were phagocytozed in the same proportion by G. mellonella hemocytes after 2 h of infection (Fig. 2D) . In order to better characterize the development of NAC infections in G. mellonella, we performed histopathological analyses. The evaluation of sagittal sections showed the morphology of the G. mellonella cuticle and internal organs interspersed by fragments of fat body and muscle fibers (Fig. 3A) . All the Candida species triggered a rapid progression of infection, with round hemocytes recruitment being observed in melanized nodules entrapping fungal cells (Fig. 3B-H) .
Differences among NAC species virulence in G. mellonella can be related to differences in their growth rate and production of potential virulence attributes Overall, the fungal growth curves were all typically sigmoidal; however, clear differences in the lengths of the lag and log periods were noticeably observed (Fig. 4A) . In this context, the growth rates of C. tropicalis, C. krusei and C. lusitaniae were faster than the growth rates of C. haemulonii species complex when cultivated in SAB at 37
• C (Fig. 4A) .
In order to detect a possible modulation in the physiology of these NAC species, virulence potential was measured under two settings: in a pre-and post-G. mellonella passage model. From all NAC species, C. haemulonii presented the maximum biofilm formation after 48 h under both experimental conditions (Fig. 4B-D) . In the post-passage condition, biofilm formation of all the fungal species greatly increased in terms of biomass, viability and extracellular matrix production ( Fig. 4B-D) . Taking into consideration the production of different classes of hydrolytic enzymes, in the pre-passage model C. tropicalis and C. lusitaniae were excellent producers of aspartic protease (Pz means of 0.23 and 0.32, respectively), caseinase (Pz means of 0.32 and 0.38, respectively) and phytase (Pz means of 0.35 and 0.33, respectively), while C. krusei and C. haemulonii species complex are considered good or weak producers of the previously reported enzymes. Candida tropicalis, C. lusitaniae and C. haemulonii were good producers of esterase (Pz means of 0.46, 0.46 and 0.49, respectively), whereas only C. tropicalis is considered a good producer of phospholipase (Fig. 4E-I) . Although a heterogeneous pattern of hydrolytic enzymes production was observed among fungal species, no significant differences were detected between the two employed conditions: pre-and post-passage in G. mellonella model.
In vitro antifungal susceptibility profiles of NAC species
The MIC values of AMB, FLC, ITC, VRC and CAS were summarized in Table 2 . Candida tropicalis was susceptible to all tested antifungals, whereas C. krusei was resistant to FLC (MIC = 64 mg/L) and ITC (MIC = 1 mg/L) and C. lusitaniae was resistant to AMB (MIC = 1 mg/L). In a comparative way, since no official breakpoints were established yet, all the clinical isolates of C. haemulonii species complex were considered resistant to the azoles FLC (MIC > 64 mg/L), ITC (MIC ≥ 8 mg/L) and VRC (MIC > 16 mg/L) as well as AMB (MIC ≥ 2 mg/L) as previously proposed (Ramos et al. 2015) . All the studied NAC species were susceptible to CAS (MIC ≤ 0.5 mg/L) ( Table 2 ).
In vivo antifungal susceptibility profiles of NAC species on G. mellonella model
In order to evaluate whether G. mellonella can be used as an in vivo model to test the efficacy of antifungals during NAC species infection, infected larvae (3 × 10 6 or 6 × 10 6 fungi/larva) were treated (single dose) with FLC, AMB and CAS. Larvae infected with C. tropicalis and treated with FLC (6 and 12 mg/kg), AMB (2.5 and 5 mg/kg) and CAS (0.5 and 1 mg/kg) were protected from infection (Figs 5-7A) when compared with the untreated group. For C. krusei infection, FLC did not protect the larvae at both concentrations used, while AMB and CAS had a protective effect (Figs 5-7B ). Larvae infected with C. lusitaniae were protected from infection by both FLC and CAS in all the tested concentrations, whereas AMB protected only at the highest concentration (Figs 5-7C) . Regarding the C. haemulonii species complex infections, only CAS had a protective effect (Figs. 5-7D-F and Fig. S1 , Supporting Information). None of the drugs were toxic to the larvae at the tested concentrations (data not shown). Furthermore, we evaluated the fungal burden during the infection progression in G. mellonella as well as the effect of antifungals at highest doses (FLC at 12 mg/kg, AMB at 5 mg/kg and CAS at 1 mg/kg) in this in vivo model. In PBS-treated larvae, the CFUs significantly increased after 48 h as compared to the initial inoculum (0 h) (Fig. 8) . The treatment of larvae infected with C. tropicalis with FLC, AMB and CAS decreased the number of CFUs by at least 100-fold (Fig. 8A) . In larvae infected with C. krusei, AMB and CAS reduced the fungal burden by around 100-fold whereas FLC caused a less pronounced, but significant, decrease in the number of recovered fungal cells (Fig. 8B) . For C. lusitaniae infection, FLC and CAS reduced the fungal burden by 100-fold, while AMB reduced significantly less (Fig. 8C) . Regarding C. haemulonii species complex infections, only CAS considerably reduced the fungal burden ( Fig. 8D-F) .
DISCUSSION
Galleria mellonella has been used to study pathogenesis of many fungal species, displaying a strong correlation with mammalian models (Brennan et al. 2002; Slater et al. 2011) . In this work, we have demonstrated for the first time that G. mellonella can be used to evaluate the pathogenicity of C. haemulonii species complex and also confirmed the pathogenicity of three clinically relevant NAC species, C. tropicalis , C. krusei (Scorzoni et al. 2013) and C. lusitaniae (Rossoni et al. 2013) , in this invertebrate model. The virulence of all the tested NAC species in G. mellonella was inoculum-dependent, which is related to data found with other fungal pathogens, such as C. albicans and Cryptococcus neoformans (Cotter, Doyle and Kavanagh 2000; Mylonakis et al. 2005 ). The differences in virulence among C. haemulonii species complex and other NAC species can be explained, at least in part, by differences in both fungal growth rates and production of hydrolytic enzymes. The observation that C. haemulonii species complex grew more slowly in vitro and produced a lesser amount of enzymatic activities are in agreement with Rossoni et al. (2013) , who first correlated in vitro enzyme production and in vivo pathogenicity. In the present work, intraspecies virulence differences in C. haemulonii species complex could not be noticeably observed due to the few strains used.
In vivo passage experiments can be used to study virulence factors that are important for local adaptation in a stressed host environment (Ebert 1998) . For instance, NAC passage through the larvae significantly increased the biofilm formation in terms of biomass, matrix and metabolic activity, but not the production of extracellular hydrolytic enzymes, at least under the employed experimental conditions. However, we cannot rule out the hypothesis of the participation of enzymes released by NAC species on the pathogenicity of G. mellonella larvae.
Melanization is a humoral response of the insect that causes the elimination of pathogens by the activation of the phenoloxidase cascade, which produces molecules that are very toxic to microorganisms and also help in the phagocytosis process (Binggeli et al. 2014) . The encapsulation event occurs when the larval cells were unable to phagocyte the pathogens and thus try to control the invasion by creating a cell barrier (Jiravanichpaisal, Lee and Söderhäll 2006). We observed a fast melanization process after infection with all the NAC species and the degree of melanization was dependent on the inoculum size. Additionally, encapsulation, melanization and granuloma-like structures were observed in the histopathology analyses of G. mellonella larvae. Furthermore, the histopathology of 24 hinfected larvae showed that all Candida species studied were able to multiply inside the larvae and destroyed the G. mellonella tissues, which corroborated the larvae death. Reduction in the hemocyte counts has been correlated with increased pathogenicity of a range of yeast isolates during infection in G. mellonella (Bergin, Brennan and Kavanagh 2003) . After just 2 h of infection, all the NAC species tested induced a reduction in the proportion of hemocytes in a similar way. This result suggests a mechanism of phagocytosis avoidance through which Candida species induce killing of G. mellonella, but does not explain the differences in virulence shown by the different Candida spp. as previously suggest by Mesa-Arango et al. (2013) . Also, phagocytosis percentage of hemocytes presented no statistical differences among all fungal species tested, possibly because these fungi should be recognized by the same pattern recognition receptors of phagocytes.
Standardized measurements of in vitro antifungal activity in terms of MIC are important to guide clinical therapeutic indications and are expected to correlate with its efficacy in vivo. Thus, the studies using animal models serve to produce pre-clinical data in order to guide drug dosing in subsequent clinical trials. Our work showed the correlation between the in vitro susceptibility profiles and in vivo G. mellonella efficacy of equivalent human therapeutic doses of antifungals during NAC species infections. Most importantly, we have shown, in both in vitro and in vivo approaches, that C. haemulonii species complex infections could be controlled only with CAS treatment. Similar findings have been demonstrated in a model of murine hematogenous candidiasis regarding C. krusei and C. lusitaniae (Anaissie et al. 1994) , which corroborates our results with haemulonii var. vulnera LIPCh9. Results are expressed as Log CFU/larva, and horizontal bars represent the median value of larval burden per group (5 larvae). Statistical differences are highlighted ( * P > 0.05 or * * P > 0.01) to the larvae group that was infected and received only PBS at same time point.
G. mellonella and validates the use of non-mammalian models to study antifungal efficacy against NAC species. Due to the simplicity of this model, it can be used as an alternative in vivo system to evaluate drug toxicity and antifungal efficacy (Kavanagh and Fallon 2010) . Furthermore, the survival experiments were directly correlated to the fungal burden observed in the larvae. For C. haemolunii species complex, only CAS had fungicidal action and was able to expressively reduce the fungal burden. In agreement with our data, Kim et al. (2011) treated and cured only with CAS an adult patient in long-term hospital care possessing a catheter-related candidemia caused by C. haemulonii, despite the initial treatment with FLC. Non-conventional hosts like G. mellonella have drawn attention as important alternative models for in vivo studies particularly for fungal species, mainly Candida (Fuchs et al. 2010; MesaArango et al. 2013; Scorzoni et al. 2013; Gago et al. 2014; Borman, Szekely and Johnson 2016; Ames et al. 2017) . Galleria mellonella model present some advantages, such as being more ethically acceptable; inexpensive, allowing the use of more individuals to increase the statistical power of the assay; the easy manipulation of larvae; the ability to assay at 37
• C; and also evaluation of species that present low virulence in mammalian systems (Jacobsen 2014) . Our results also demonstrated the feasibility of G. mellonella model to identify the activity of antifungal compounds against resistant Candida species. The severe difficulty encountered in the treatment of infections caused especially by the resistant C. haemulonii species complex highlights the need to explore new alternative therapeutic approaches.
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